Table 3.

The different levels of inflammation parameters divided by metabolic disorders or their components.

	MHR	NLR	SII	SIRI
	M ± SD	M ± SD	M ± SD	M ± SD
MetD
Yes	0.49 ± 0.25	1.96 ± 1.00	392.60 ± 225.82	1.24 ± 0.83
No	0.33 ± 0.22	1.89 ± 0.98	370.30 ± 234.70	0.82 ± 0.62
p	<0.001	0.017	<0.001	<0.001
MetS
Yes	0.44 ± 0.28	1.92 ± 1.07	391.40 ± 238.51	0.97 ± 1.09
No	0.36 ± 0.23	1.27 ± 0.80	379.64 ± 201.63	0.92 ± 0.79
p	<0.001	0.027	0.042	0.018
Dyslipidemia
Yes	0.40 ± 0.25	1.89 ± 0.97	394.10 ± 226.95	0.94 ± 0.83
No	0.34 ± 0.23	1.94 ± 1.07	378.03 ± 229.36	0.82 ± -.61
p	<0.001	0.051	0.009	<0.001
Central obesity
Yes	0.42 ± 0.28	1.87 ± 1.06	389.20 ± 210.27	0.95 ± 1.06
No	0.36 ± 0.22	1.93 ± 0.86	390.87 ± 238.96	0.92 ± 0.75
p	<0.001	0.757	0.163	0.011
Hypercholesterolemia
Yes	0.56 ± 0.24	1.96 ± 0.94	391.70 ± 230.29	1.39 ± 1.00
No	0.40 ± 0.20	1.55 ± 1.04	368.61 ± 224.85	0.94 ± 0.76
p	<0.001	<0.001	<0.001	<0.001
Hypertriglyceridemia
Yes	0.45 ± 0.28	1.91 ± 1.06	394.32 ± 207.53	1.22 ± 1.00
No	0.35 ± 0.23	1.88 ± 0.85	378.13 ± 236.98	0.90 ± 0.76
p	<0.001	0.021	<0.001	<0.001
High LDL-C
Yes	0.37 ± 0.26	1.92 ± 1.02	401.50 ± 216.32	1.39 ± 1.13
No	0.38 ± 0.24	1.54 ± 0.89	386.49 ± 231.10	0.94 ± 0.80
p	0.089	0.01	<0.001	<0.001
Low HDL-C
Yes	0.47 ± 0.29	1.90 ± 0.84	400.04 ± 216.62	1.10 ± 0.95
No	0.34 ± 0.21	1.90 ± 1.06	385.15 ± 232.92	0.93 ± 0.76
p	<0.001	0.429	<0.001	<0.001

Data are presented as M ± SD. Statistical significance was defined at p < 0.05 under two-tailed conditions. HDL-C, high-density lipoprotein cholesterol; LDL-C. low-density lipoprotein cholesterol; M, mean; MetD, metabolic disorders; MetS, metabolic syndrome; MHR, monocyte-to-high-density lipoprotein ratio; NLR, neutrophil-to-lymphocyte ratio; SD, standard deviation; SII, systematic immune-inflammation index; SIRI, systemic inflammation response index.